GlaxoSmithKline PLC
NYSE:GSK

Watchlist Manager
GlaxoSmithKline PLC Logo
GlaxoSmithKline PLC
NYSE:GSK
Watchlist
Price: 40.86 USD -3.84% Market Closed
Market Cap: 83.3B USD

Intrinsic Value

The intrinsic value of one GSK stock under the Base Case scenario is 52.86 USD. Compared to the current market price of 40.86 USD, GlaxoSmithKline PLC is Undervalued by 23%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

GSK Intrinsic Value
52.86 USD
Undervaluation 23%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
GlaxoSmithKline PLC

Valuation History Unavailable

Historical valuation for GSK cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%
Compare GSK to

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about GSK?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about GlaxoSmithKline PLC
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
GlaxoSmithKline PLC

Current Assets 18.1B
Cash & Short-Term Investments 4.5B
Receivables 7.5B
Other Current Assets 6.1B
Non-Current Assets 42.6B
Long-Term Investments 1B
PP&E 10B
Intangibles 23.2B
Other Non-Current Assets 8.4B
Efficiency

Free Cash Flow Analysis
GlaxoSmithKline PLC

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
GlaxoSmithKline PLC

Revenue
31.5B GBP
Cost of Revenue
-8.8B GBP
Gross Profit
22.7B GBP
Operating Expenses
-14.8B GBP
Operating Income
7.9B GBP
Other Expenses
-4.7B GBP
Net Income
3.2B GBP
Fundamental Scores

GSK Profitability Score
Profitability Due Diligence

GlaxoSmithKline PLC's profitability score is 69/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Year Average ROE
Positive Gross Profit
Positive Free Cash Flow
Positive Operating Income
69/100
Profitability
Score

GlaxoSmithKline PLC's profitability score is 69/100. The higher the profitability score, the more profitable the company is.

GSK Solvency Score
Solvency Due Diligence

GlaxoSmithKline PLC's solvency score is 46/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
Long-Term Solvency
Average D/E
Short-Term Solvency
46/100
Solvency
Score

GlaxoSmithKline PLC's solvency score is 46/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

GSK Price Targets Summary
GlaxoSmithKline PLC

Wall Street analysts forecast GSK stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for GSK is 45 USD with a low forecast of 32.17 USD and a high forecast of 75.19 USD.

Lowest
Price Target
32.17 USD
21% Downside
Average
Price Target
45 USD
10% Upside
Highest
Price Target
75.19 USD
84% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for GSK is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

GSK Insider Trading
Buy and sell transactions by insiders

GSK News

Other Videos
What is the Intrinsic Value of one GSK stock?

The intrinsic value of one GSK stock under the Base Case scenario is 52.86 USD.

Is GSK stock undervalued or overvalued?

Compared to the current market price of 40.86 USD, GlaxoSmithKline PLC is Undervalued by 23%.

Back to Top